Recent Advances in the Treatment Landscape for the Patient With BCG Unresponsive NMIBC

Medscape
Europe/Berlin CET+2

Description

This interactive symposium will start by providing an introduction on how to identify a patient with bacillus Calmette-Guérin (BCG) unresponsive high-risk non-muscle invasive bladder cancer (NMBIC) followed by an overview of the current and emerging treatment options for this patient population. Finally, the experts will present a clinical case of a patient treated with BCG therapy who becomes unresponsive and will discuss the available treatment options and the clinical implications of the latest clinical data. Attendees will have the opportunity to submit questions to be addressed throughout the program.

 

 

Topics:

 

Who Is the Patient With BCG Unresponsive NMIBC?,

Clinical Trial Updates for the BCG Unresponsive Patient,

The BCG Unresponsive Patient: A Patient Case

Shahrokh F. Shariat

Who Is the Patient With BCG Unresponsive NMIBC?, Clinical Trial Updates for the BCG Unresponsive Patient, The BCG Unresponsive Patient: A Patient Case

Inglês

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES
 

Speakers

Marek Babjuk, Ashish M. Kamat, Joan R. Palou

 
 
 
 

Download the Agenda

Search for our next event. See you soon!

Subscribe to get news on all upcoming events

who%20goals_edited.png

DocMeeetings

Social Media

  • Twitter DocMeetings
  • Instagram DocMeetings
  • Facebook ícone social
  • LinkedIn ícone social

contact us

Adress

Sao Paulo, SP - Brazil

© 2020 by Docmeetings - A DocMeetings.com Company
Site Managed by:
QUALITY Soluções Web
1996-2020 "24 years inspiring technology"